Search
for
Sort by
Research 271–300 of 1000+
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period
- The antiandrogenic effect of finasteride against a mutant androgen receptor
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Comparison of clinical trials with finasteride and dutasteride.
- Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
- Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method
- The effect of finasteride and dutasteride on the synthesis of neurosteroids by glioblastoma cells
- Repeated finasteride administration induces depression-like behavior in adult male rats
- Hidradenitis Suppurativa in Children Treated with Finasteride-A Case Series
- Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study
- Persistent Sexual Dysfunction with Finasteride 1 mg Taken for Hair Loss
- A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness
- Solubilities of Flutamide, Dutasteride, and Finasteride as Antiandrogenic Agents, in Supercritical Carbon Dioxide: Measurement and Correlation
- Further errors in polymorph identification: furosemide and finasteride
- Finasteride delays the onset of maternal behavior in primigravid rats
- A STABILITY-INDICATING HPLC METHOD TO DETERMINE FINASTERIDE IN A TABLET FORMULATION
- High-performance liquid chromatographic method for the determination of finasteride in human plasma at therapeutic doses
- Enhancement of Dermal Delivery of Finasteride Using MicroemulsionSystems
- Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey‐based, single‐centre, controlled study
- Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway
- Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor
- Rapid determination of finasteride in human plasma by UPLC–MS/MS and its application to clinical pharmacokinetic study
- Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
- Exposure of Xenopus laevis tadpoles to finasteride, an inhibitor of 5-α reductase activity, impairs spermatogenesis and alters hypophyseal feedback mechanisms
- A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism
- Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old
- Mechanism of Salutary Effects of Finasteride on Post-traumatic Immune/Inflammatory Response
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism